HLA Region and KIR Genomics in Common Variable Immune Deficiency

常见变异性免疫缺陷病中的 HLA 区域和 KIR 基因组学

基本信息

项目摘要

DESCRIPTION (provided by applicant): Common variable immunodeficiency (CVID) is a clinical diagnosis given to patients who suffer with unexplained deficiencies of serum immunoglobulins. Most CVID patients present with recurrent sinopulmonary infections. Among our clinic population, the greatest genetic linkage is to the major histocompatibility complex (MHC) on chromosome 6, with more than 80% of our patients inheriting either HLA*B08 or HLA*B44. We recently characterized a separate group of clinic patients who presented with adult-onset recurrent sinopulmonary infections (RESPI) and serum immunoglobulin levels above the threshold for diagnosis with CVID, but with the same distribution of HLA*B08 and HLA*B44 as that seen in CVID. Recognition of RESPI patients among first and second degree relatives of CVID patients, including two identical twins discordant for RESPI and CVID, led us to the hypothesis that RESPI patients are suffering from the effects of the same genetic susceptibility to immune dysfunction that manifests more severely in classic CVID. Careful analysis has shown a variety of abnormalities in either the number or function of a number of different lymphocyte subsets in both RESPI and CVID patients. For example, NK cells have been reported to be depressed in number, but the role of factors that can mediate NK cell function, including the role of KIR and MHC ligands, remains unknown. We propose to use our population of RESPI/CVID patients to map the putative common susceptibility gene for RESPI/CVID within the MHC, to characterize HLA/KIR interactions, and to evaluate the expressed B cell and T cell antigen receptor repertoires in these patients. This comprehensive analysis of the MHC, KIR, BCR and TCR could help define and extend the spectrum of what is already the most common primary immune deficiency under the care of clinical immunologists in the US, as well as to elucidate the mechanism(s) that underlie susceptibility to infection, facilitate diagnosis, and point to new avenues for prevention and treatment. PUBLIC HEALTH RELEVANCE (provided by applicant): Findings from this proposal will be used to define the relationships between the MHC, KIR, the BCR and TCR repertoires and their functional relevance to the pathogenesis and clinical course of CVID and RESPI.
描述(由申请方提供):常见变异型免疫缺陷(CVID)是对患有原因不明的血清免疫球蛋白缺乏症的患者进行的临床诊断。大多数CVID患者表现为反复鼻窦感染。在我们的临床人群中,最大的遗传连锁是6号染色体上的主要组织相容性复合体(MHC),超过80%的患者遗传HLA* B 08或HLA*B44。我们最近对一组临床患者进行了特征分析,这些患者表现为成人复发性鼻窦炎感染(RESPI),血清免疫球蛋白水平高于CVID诊断阈值,但HLA* B 08和HLA*B44的分布与CVID相同。在CVID患者的一级和二级亲属中识别RESPI患者,包括两个RESPI和CVID不一致的同卵双胞胎,使我们假设RESPI患者遭受相同的遗传易感性对免疫功能障碍的影响,在经典CVID中表现得更严重。仔细分析表明,RESPI和CVID患者中许多不同淋巴细胞亚群的数量或功能存在各种异常。例如,据报道NK细胞的数量减少,但可以介导NK细胞功能的因子的作用,包括KIR和MHC配体的作用,仍然未知。我们建议使用我们的RESPI/CVID患者群体来绘制MHC内RESPI/CVID的推定共同易感基因,以表征HLA/KIR相互作用,并评估这些患者中表达的B细胞和T细胞抗原受体库。这种对MHC、KIR、BCR和TCR的全面分析可以帮助定义和扩展在美国临床免疫学家的护理下已经是最常见的原发性免疫缺陷的范围,以及阐明感染易感性的机制,促进诊断,并指出预防和治疗的新途径。 公共卫生相关性(由申请方提供):本提案的结果将用于定义MHC、KIR、BCR和TCR库之间的关系及其与CVID和RESPI发病机制和临床病程的功能相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Harry William Schroeder其他文献

Harry William Schroeder的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Harry William Schroeder', 18)}}的其他基金

Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression
免疫球蛋白 DQ52 DH 基因片段在胎儿免疫抑制中的作用
  • 批准号:
    10596627
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
Role of the immunoglobulin DQ52 DH gene segment in fetal immunosuppression
免疫球蛋白 DQ52 DH 基因片段在胎儿免疫抑制中的作用
  • 批准号:
    10451016
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
The pre-BCR CDR-H3 sensing site and H chain selection
BCR前CDR-H3传感位点和H链选择
  • 批准号:
    9089913
  • 财政年份:
    2015
  • 资助金额:
    $ 48.66万
  • 项目类别:
The pre-BCR CDR-H3 sensing site and H chain selection
BCR前CDR-H3传感位点和H链选择
  • 批准号:
    8987028
  • 财政年份:
    2015
  • 资助金额:
    $ 48.66万
  • 项目类别:
The Role of Immunoglobulin CDRH3 in Autoimmune Disease
免疫球蛋白 CDRH3 在自身免疫性疾病中的作用
  • 批准号:
    8513453
  • 财政年份:
    2012
  • 资助金额:
    $ 48.66万
  • 项目类别:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
常见变异性免疫缺陷病中的 HLA 区域和 KIR 基因组学
  • 批准号:
    8320328
  • 财政年份:
    2010
  • 资助金额:
    $ 48.66万
  • 项目类别:
HLA Region and KIR Genomics in Common Variable Immune Deficiency
常见变异性免疫缺陷病中的 HLA 区域和 KIR 基因组学
  • 批准号:
    8115993
  • 财政年份:
    2010
  • 资助金额:
    $ 48.66万
  • 项目类别:
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virus
免疫球蛋白CDR-H3在流感病毒异亚型免疫中的作用
  • 批准号:
    8103875
  • 财政年份:
    2010
  • 资助金额:
    $ 48.66万
  • 项目类别:
Role of IG CDR-H3 in Responses to HIV Vaccines
IG CDR-H3 在 HIV 疫苗反应中的作用
  • 批准号:
    8489257
  • 财政年份:
    2010
  • 资助金额:
    $ 48.66万
  • 项目类别:
Role of IG CDR-H3 in Responses to HIV Vaccines
IG CDR-H3 在 HIV 疫苗反应中的作用
  • 批准号:
    8294974
  • 财政年份:
    2010
  • 资助金额:
    $ 48.66万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 48.66万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 48.66万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 48.66万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 48.66万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 48.66万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 48.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了